Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 28, 2022; 28(40): 5865-5880
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5865
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5865
Figure 1 Drugs and protocols used in the study.
A: Molecular structural formula of curcumin (Cur); B: Cur used in the experiment; C: Colitis induction and Cur administration. The experiment lasted for 22 d, including 3 d of adaptive feeding, 0-7 d of treatment with 3% DSS treatment with drinking water, and 7 d of free drinking water. Animals were divided into four groups: Control (n = 10), DSS (n = 10), DSS + Cur (100 mg/kg/d, n = 10), and Ctrl + Cur (100 mg/kg/d, n = 10) groups.
- Citation: Wei SY, Wu TT, Huang JQ, Kang ZP, Wang MX, Zhong YB, Ge W, Zhou BG, Zhao HM, Wang HY, Liu DY. Curcumin alleviates experimental colitis via a potential mechanism involving memory B cells and Bcl-6-Syk-BLNK signaling. World J Gastroenterol 2022; 28(40): 5865-5880
- URL: https://www.wjgnet.com/1007-9327/full/v28/i40/5865.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i40.5865